Equity Analysis

Quarterly Results

    Glaxosmithkline Pharmaceuticals Ltd
    Industry :  Pharmaceuticals - Multinational
    BSE Code
    ISIN Demat
    Book Value()
    500660
    INE159A01016
    91.3566062
    NSE Symbol
    P/E(TTM)
    Mar.Cap( Cr.)
    GLAXO
    55.81
    35471.08
    EPS(TTM)
    Face Value()
    Div & Yield %:
    37.52
    10
    1.53
     
Quarters
(RupeeIcon Cr)
ParticularsDec 2023Sep 2023Jun 2023
Gross Sales804.98953.38738.02
Other Operating Income0.000.000.00
Other Income 28.3428.4754.10
Total Income833.32981.85792.12
Total Expenditure 750.78666.80596.77
PBIDT82.54315.05195.35
Interest 0.320.430.28
PBDT82.22314.62195.07
Depreciation17.1118.1116.36
Tax31.3290.6052.63
Fringe Benefit Tax0.000.000.00
Deferred Tax-11.70-9.63-4.50
Reported Profit After Tax45.49215.54130.58
Extra-ordinary Items -131.990.0012.21
Adjusted Profit After Extra-ordinary item177.48215.54118.37
EPS (Unit Curr.)2.6912.726.94
EPS (Adj) (Unit Curr.)2.6912.726.94
Calculated EPS (Unit Curr.)2.6912.727.71
Calculated EPS (Adj) (Unit Curr.)2.6912.727.71
Calculated EPS (Ann.) (Unit Curr.)10.7450.8930.83
Calculated EPS (Adj) (Ann.) (Unit Curr.)10.7450.8930.83
Book Value (Unit Curr.)0.000.000.00
Dividend (%)0.00320.000.00
Equity169.41169.41169.41
Reserve & Surplus0.000.000.00
Face Value10.0010.0010.00
Public Shareholding (No. Of Shares)0.000.000.00
Public Shareholding (% in Equity)0.000.000.00
Pledged/Encumbered - No. of Shares0.000.000.00
Pledged/Encumbered - % in Total Promoters Holding0.000.000.00
Pledged/Encumbered - % in Total Equity0.000.000.00
Non Encumbered - No. of Shares0.000.000.00
Non Encumbered - % in Total Promoters Holding0.000.000.00
Non Encumbered - % in Total Equity0.000.000.00
PBIDTM(%)10.2533.0526.47
PBDTM(%)10.2133.0026.43
PATM(%)5.6522.6117.69
Dividend Per Share(Rs)0.0032.000.00
Diluted EPS2.6912.727.71